| Literature DB >> 34162343 |
Ingmar Schäfer1, Heike Hansen2, Agata Menzel2, Marion Eisele2, Daniel Tajdar2, Dagmar Lühmann2, Martin Scherer2.
Abstract
OBJECTIVES: The aims of our study were to describe the effect of the COVID-19 pandemic and lockdown on primary care in Germany regarding the number of consultations, the prevalence of specific reasons for consultation presented by the patients, and the frequency of specific services performed by the GP.Entities:
Keywords: Covid-19; Health care utilisation; Primary care
Year: 2021 PMID: 34162343 PMCID: PMC8221278 DOI: 10.1186/s12875-021-01471-3
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Association between covid-19 lockdown and the number of treated patients: results of a multivariate linear regression adjusted for random effects on the levels of German federal states, administrative districts within the federal states and GP practices
| Days since lockdown on 13 March 2020 | -0.34 (-1.3 to 0.57) | 0.466 | -0.30 (-1.2 to 0.61) | 0.517 | -0.29 (-1.2 to 0.60) | 0.522 |
| Days between baseline and follow-up | 0.043 (-0.017 to 0.10) | 0.160 | 0.041 (-0.021 to 0.10) | 0.193 | 0.061 (-0.0018 to 0.12) | 0.057 |
| Region: urban areas vs. rural areas | 13.5 (-8.9 to 35.8) | 0.238 | 12.1 (-11.4 to 35.6) | 0.312 | 6.1 (-18.2 to 30.3) | 0.622 |
| Age of the physician (in years) | 0.99 (-0.47 to 2.4) | 0.184 | 0.58 (-0.87 to 2.0) | 0.434 | ||
| Sex of the physician: male vs. female | 10.4 (-13.9 to 34.7) | 0.400 | 14.0 (-9.8 to 37.8) | 0.249 | ||
| Postgraduate medical specialist training | ||||||
| - None (general practitioner) | -39.0 (-131.9 to 53.9) | 0.410 | -53.8 (-146.2 to 38.7) | 0.254 | ||
| - General medicine | 23.3 (-21.3 to 68.0) | 0.305 | 20.6 (-23.2 to 64.3) | 0.357 | ||
| - Internal medicine | 10.3 (-28.2 to 48.7) | 0.601 | 9.5 (-27.9 to 46.9) | 0.617 | ||
| - Medical care centre vs. individual practice | 8.2 (-73.3 to 89.8) | 0.843 | ||||
Model 1: naïve comparison adjusted for differences between administrative districts, the time since lockdown on 13 March 2020 and the time between baseline and follow-up; model 2: model 1 additionally adjusted for age, sex, and postgraduate medical specialist training of the GP; model 3: model 2 additionally adjusted for the type of practice; ß: ß correlation coefficient; 95% CI: 95% confidence interval; p: p-value
Change between baseline and follow-up in the frequency per week of reasons for consultationa
| Adverse drug reaction | 8.5 ± 22.0 | 4.2 ± 4.7 | -50.5% | 0.054 | 0.157 |
| Lipid metabolism disorder | 22.0 ± 37.3 | 13.7 ± 24.1 | -37.6% | 0.059 | 0.156 |
| Lower gastrointestinal tract | 11.7 ± 15.2 | 7.4 ± 14.6 | -36.9% | 0.038 | 0.157 |
| Weight/dietary problems | 19.5 ± 45.6 | 12.3 ± 35.3 | -36.8% | 0.205 | 0.397 |
| High blood pressure | 40.0 ± 45.8 | 26.9 ± 44.1 | -32.8% | 0.037 | 0.176 |
| Somatoform disorders | 22.3 ± 26.2 | 15.3 ± 23.7 | -31.6% | 0.043 | 0.156 |
| Lymph/leg oedema, chronic wounds | 6.9 ± 9.2 | 5.0 ± 7.2 | -28.1% | 0.090 | 0.218 |
| Coronary heart disease | 16.4 ± 21.5 | 12.0 ± 35.2 | -26.7% | 0.279 | 0.477 |
| Congestive heart failure | 12.1 ± 16.9 | 8.9 ± 16.7 | -26.3% | 0.175 | 0.390 |
| Cardiac arrhythmia | 12.0 ± 18.5 | 9.3 ± 10.0 | -22.3% | 0.194 | 0.402 |
| Dementia | 8.4 ± 15.3 | 6.8 ± 11.8 | -19.2% | 0.393 | 0.569 |
| Diabetes mellitus (all types) | 21.9 ± 26.3 | 17.7 ± 27.6 | -19.2% | 0.263 | 0.477 |
| Thyroid disorder | 10.2 ± 17.3 | 9.5 ± 23.4 | -6.0% | 0.832 | 0.862 |
| Arthrosis of the large joints | 9.6 ± 9.2 | 9.7 ± 14.1 | 1.9% | 0.914 | 0.914 |
| Shoulder pain | 6.6 ± 6.7 | 6.9 ± 9.0 | 5.2% | 0.756 | 0.812 |
| Acute infections of the respiratory tract | 40.2 ± 39.1 | 42.6 ± 45.9 | 5.9% | 0.686 | 0.795 |
| Mild mental disorders | 15.3 ± 18.5 | 16.5 ± 28.2 | 7.5% | 0.730 | 0.814 |
| Headache | 9.2 ± 9.3 | 10.3 ± 13.6 | 11.9% | 0.497 | 0.626 |
| Urinary tract infection | 5.8 ± 4.4 | 6.7 ± 7.6 | 15.4% | 0.296 | 0.476 |
| Chronic obstructive pulmonary disease | 7.3 ± 9.1 | 8.7 ± 15.3 | 19.5% | 0.420 | 0.580 |
| Family, partnership problems | 9.1 ± 16.2 | 11.2 ± 22.2 | 24.0% | 0.421 | 0.555 |
| Chronic kidney disease | 5.7 ± 15.4 | 7.1 ± 21.2 | 24.5% | 0.588 | 0.711 |
| Asthma | 6.3 ± 9.9 | 8.1 ± 15.0 | 27.4% | 0.326 | 0.497 |
| Workplace issues, unemployment | 7.0 ± 9.3 | 13.3 ± 30.3 | 90.2% | 0.045 | 0.144 |
a sorted in ascending order by change between baseline and follow-up; b α-level Benjamini-Hochberg-adjusted for 29 statistical tests; statistically significant results in bold and italic
Change between baseline and follow-up in the frequency per week of performed servicesa
| Local injection/infiltration | 16.6 ± 43.2 | 7.7 ± 11.1 | -53.5% | 0.039 | 0.061 |
| Physical therapy | 9.2 ± 16.9 | 5.1 ± 11.5 | -45.1% | 0.037 | 0.063 |
| Nutrition counselling | 16.7 ± 27.0 | 10.3 ± 24.1 | -38.0% | 0.070 | 0.103 |
| Disease management programme (DMP) | 21.0 ± 20.1 | 17.3 ± 19.5 | -17.7% | 0.181 | 0.249 |
| Psychosomatic basic care | 24.2 ± 26.7 | 22.3 ± 27.1 | -7.8% | 0.622 | 0.652 |
| Vaccination | 16.1 ± 14.2 | 15.0 ± 13.8 | -7.1% | 0.563 | 0.652 |
| Social medical assessments | 4.8 ± 4.7 | 5.1 ± 6.3 | 6.3% | 0.689 | 0.689 |
| Lifestyle counselling, social counselling | 36.8 ± 53.1 | 39.9 ± 46.5 | 8.4% | 0.616 | 0.677 |
| Continuous care for the chronically ill | 82.8 ± 78.8 | 99.4 ± 239.4 | 20.0% | 0.479 | 0.585 |
| Organisation of patient care/support | 8.2 ± 10.9 | 10.5 ± 16.4 | 28.5% | 0.200 | 0.259 |
a sorted in ascending order by change between baseline and follow-up; b α-level Benjamini-Hochberg-adjusted for 22 statistical tests; statistically significant results in bold and italic; c From the age of 35, the health insurance pays a regular health check-up every three years. The check-up 35 comprises anamnesis (particularly regarding the risk profile), physical examination (including measurement of blood pressure), blood examination (including lipid profile and glucose), urine examination (including protein, glucose, red and white blood cells, nitrite), medical advice concerning the test results and – if medically indicated – prevention recommendations [23]